Última Hora: "Governo admite rever portagens nas vias do interior do país - Observador" Thu, 16 Nov 2017 11:22:22 GMT    "Isabel dos Santos diz que financiamento que deixa na Sonangol vem da China e da Europa - Jornal de Negócios - Portugal" Fri, 17 Nov 2017 21:01:22 GMT    "PONTOS ESSENCIAIS/OE2018: Partidos apresentam mais de 600 propostas de alteração - Diário de Notícias - Lisboa" Sat, 18 Nov 2017 01:42:11 GMT   "This RSS feed URL is deprecated" Sat, 18 Nov 2017 07:02:20 GMT    "Europa: Transferências bancárias vão ser instantâneas e grátis - Pplware" Fri, 17 Nov 2017 23:03:45 GMT    "Combustíveis vão descer pela primeira vez em cinco semanas - Jornal de Negócios - Portugal" Fri, 17 Nov 2017 12:47:05 GMT    "Em atualização Serviço universal no telefone fixo pode ter fim à vista. Desde 2014 só há 2 clientes - SAPO Tek" Fri, 17 Nov 2017 16:36:08 GMT    "Portugal reembolsa antecipadamente ao FMI mais 2,78 mil milhões de euros - Observador" Fri, 17 Nov 2017 11:15:00 GMT    "Tesla lança caminhão, mas carro de aceleração mais rápida rouba a cena - Globo.com" Fri, 17 Nov 2017 20:06:42 GMT    "Jackpot de 60 milhões no sorteio do Euromilhões de terça-feira - Correio da Manhã" Fri, 17 Nov 2017 22:41:15 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Kala Pharmaceuticals (KALA) Names Todd Bazemore as COO
StreetInsider.com
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »

TechnoPOW (blog)

Desloratadine Market Healthcare, Clinical Reviews, Survey Reports 2017 to 2022
TechnoPOW (blog)
Leading Manufacturers Analysis in Global Desloratadine Market 2017: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt. The Global Desloratadine ...

e mais »

An Overview of Obsessive-Compulsive Disorder and Related Conditions: November 2017
Healio
Andrew A. Nierenberg, MD, has disclosed the following relevant financial relationships: Appliance Computing Inc. (Mindsite); Astra Zeneca; Brain Cells, Inc.; Brandeis University; Bristol Myers Squibb; Clintara, Dianippon Sumitomo/Sepracor; Eli Lilly ...


Directorate Change
London South East (blog)
... a member of the Board, at Vectura Group plc. Prior to this, he served as Chief Executive Officer and Chief Operating Officer at Critical Therapeutics Inc. and has also held senior management positions at Sepracor, Inc. (now Sunovion Pharmaceuticals ...


Pulmatrix (PULM) Appoints Dr. James Roach as CMO
StreetInsider.com
Pulmatrix, Inc. (NASDAQ: PULM), today announced that it has appointed James (Jim) Roach, MD, FACP, FCCP as its new Chief Medical Officer, effective November 3, 2017. Dr. Roach will lead the clinical ... Prior to joining Veristat, he served as Senior ...

e mais »

Flex Pharma Reports Third Quarter 2017 Financial Results
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments in Phase 2 randomized, controlled trials for cramps and spasticity associated with severe neurological diseases such as ...

e mais »

Pulmatrix Provides Q3 2017 Highlights and Q3 2017 Updated Financials
PR Newswire (press release)
Prior to joining Veristat, he served as Senior Vice President, Development and Chief Medical Officer of Momenta Pharmaceuticals, Senior Vice President, Medical Affairs at Sepracor Pharmaceuticals, and Head of Medical Affairs at Millennium ...


Newshawk Time

Asthma Medication Market 2017: Global Industry Analysis, Top Company, Research Forecast, Analysis and Supply ...
Newshawk Time
Asthma Medication Market Segment by Manufacturers: ? Dulera,QVAR,Glaxosmithkline plc,MAP Pharmaceuticals?Inc,Merck & Co. Inc,AstraZeneca plc,Roche Holdings Ltd,Genentech Inc,Sepracor, Inc,Schering-Plough Corp,Sanofi-Aventis,Theravance Inc ...

e mais »

Kala Pharmaceuticals Appoints Andrew I. Koven to Board of Directors
Business Wire (press release)
From 2007-2010, Mr. Koven served as Executive Vice President, General Counsel and Corporate Secretary at Sepracor Inc., where he was responsible for the company's legal and government affairs departments and Corporate Secretarial function until its ...

e mais »

ZIOPHARM Appoints Amy Trevvett Vice President of Investor Relations and Corporate Communications
GlobeNewswire (press release)
Prior to HeartWare, Ms. Trevvett served in communications and investor relations roles at both Alkermes, Inc., a global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases, and Sepracor, ...

e mais »

Novelion Therapeutics Appoints Mark Corrigan, MD to Board of Directors
GlobeNewswire (press release)
Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Prior to that, he was executive vice president, research & development of Sepracor Inc. (now Sunovion Pharmaceuticals). Prior to joining Sepracor, Dr. Corrigan spent 10 ...

e mais »

Desloratadine Sales Market Synthesis Healthcare, Clinical Reviews Reports 2017 to 2022
Equity Insider (press release)
These stakeholders include: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
Flex Pharma, Inc. (NASDAQ: FLKS), focused on developing treatments for cramps and spasms associated with severe neurological diseases, today announced the appointment of William K. McVicar, Ph.D., as President of Research and Development. ... ?With ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Yahoo Finance
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Form 8-K Acer Therapeutics Inc. For: Oct 02
StreetInsider.com
CAMBRIDGE, MA ? October 5, 2017 Acer Therapeutics Inc., (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters